Interestingly, icv leptin administration also normalizes excessive glucagon secretion and HPA axis activity in uncontrolled diabetes (34), whereas icv FGF1 injection does not — and yet, both appear to inhibit AgRP neurons, activate POMC neurons, and thereby increase net melanocortin signaling. The gene discussed is FGF1; the disease is diabetes mellitus.